New markers could improve heart attack prognosis
NCT ID NCT03070496
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This completed study followed 281 people who had a severe type of heart attack called STEMI. Researchers collected blood samples, ECGs, MRIs, and quality-of-life questionnaires to find new biological and imaging markers that could help predict outcomes like heart failure. The goal is to improve how doctors assess recovery and tailor treatment after a heart attack.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better ways to predict recovery and complications after a heart attack, improving patient care.
What could go wrong
This is an observational study, not a treatment trial. It may not directly change patient outcomes, and findings may need further validation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEMI - ST ELEVATION MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Strasbourg
Strasbourg, 67091, France
-
CHU de Tours
Tours, France
-
Hôpital Cardiovasculaire Louis Pradel
Bron, 69677, France